Zacks Investment Research on MSN

Cencora (COR) surpasses Q3 earnings estimates

Cencora (COR) came out with quarterly earnings of $4.48 per share, beating the Zacks Consensus Estimate of $4.37 per share. This compares to earnings of $4 per share a year ago. These figures are ...
Healthcare distributor Cencora (NYSE:COR) in Q2 CY2026, with sales up 5.1% year on year to $84.75 billion. Its non-GAAP ...
Carillon Tower Advisers, an investment management company, released its second-quarter 2026 investor letter for the “Carillon ...
Cor pulmonale is a condition that affects the right ventricle in the heart, altering its structure and proper functioning. It is caused by a respiratory system disorder. Pulmonary hypertension is a ...
Investors in Cencora Inc (Symbol: COR) saw new options begin trading today, for the February 2026 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is ...
(This story appeared in the July-September edition of Army AL&T;Magazine.) The importance of a contracting officer's representative (COR) in the current theater of operations cannot be overemphasized.
Cor pulmonale is a condition that happens when a respiratory disorder results in high blood pressure in the pulmonary arteries (pulmonary hypertension). The name of the condition is in Latin and means ...